Raymond James Financial
VRDN icon

Raymond James Financial’s Viridian Therapeutics VRDN Stock Holding History

Raymond James Financial’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.45M Sell
293,308
-10,466
-3% -$311K ﹤0.01% 2512
2025
Q4 		$9.42M Sell
303,774
-8,985
-3% -$246K ﹤0.01% 2012
2025
Q3 		$6.75M Sell
312,759
-19,330
-6% -$349K ﹤0.01% 2237
2025
Q2 		$4.64M Buy
332,089
+13,849
+4% +$188K ﹤0.01% 2430
2025
Q1 		$4.29M Buy
318,240
+4,453
+1% +$75.8K ﹤0.01% 2442
2024
Q4 		$6.02M Buy
+313,787
New +$6.82M ﹤0.01% 2201

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return